Financhill
Back

Cerevel Therapeutics Holdings 10K Form

Buy
63

CERE
Cerevel Therapeutics Holdings

Last Price:
41.33
Seasonality Move:
21.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CERE News And Ratings

See the #1 stock for the next 7 days that we like better than CERE

CERE Financial Statistics

Sales & Book Value

Annual Sales: $2.7M
Cash Flow: $-119.94M
Price / Cash Flow: 0
Annual Sales: $3.10
Price / Book: 13.34

Profitability

EPS (TTM): -2.73000
Net Income (TTM): $-460.47M
Gross Margin: $-2.5M
Return on Equity: 0%
Return on Assets: 0%

Cerevel Therapeutics Holdings Earnings Forecast

Key Cerevel Therapeutics Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for CERE is -92.59%.
  • The Selling, General & Administrative Expenses for CERE have been equal to 588.89% of Gross Profit Margin.
  • The Interest Expense is -2.44% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Cerevel Therapeutics Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CERE
Website: cerevel.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CERE Technical Analysis vs Fundamental Analysis

Buy
63
Cerevel Therapeutics Holdings (CERE) is a Buy

Is Cerevel Therapeutics Holdings a Buy or a Sell?